Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders
Faulds D, Goa KL, Benfield P (1993) Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45:953-1040
Usage de la cyclosporine a collyre dans la prévention du reject de greffe de cornée chez l'homme. I. Evolution préopératoire de 4 yeux atteints de kératite métaherpétique
Giochot-Bonnat L, de Beauregard C, Saragoussi JJ, Pouliquen Y (1987) Usage de la cyclosporine A collyre dans la prévention du reject de greffe de cornée chez l'homme. I. Evolution préopératoire de 4 yeux atteints de kératite métaherpétique. J Fr Ophthalmol 3:207-210
INF-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice
Hendricks RL, Tumpey TM, Finnegan A (1992) INF-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol 149:3023-3028
Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis
Meyers-Elliott RH, Chitjian PA, Billups CB (1987) Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis. Invest Ophthalmol Vis Sci 28:1170-1180
Acyclovir ointment plus betamethasone or placebo in first episode disciform keratitis
Power WJ, Hillery MP, Benedict-Smith A, Collum LMT (1992) Acyclovir ointment plus betamethasone or placebo in first episode disciform keratitis. Br J Ophthalmol 76:711-713